Fact Sheet

PhRMA USMCA Fact Sheet

PhRMA February 25, 2019

With 7,000 medicines in development across the globe, strong trade agreements are vital to facilitating global access to innovative treatments and fueling tomorrow’s new medicines and cures. The renegotiated U.S.-Mexico-Canada Agreement (USMCA) strengthens patent and other intellectual property (IP) protections for American medical innovations and raises market access and regulatory standards across North America.